| Ms Emily K Luk, MD | |
|
10333 El Camino Real, Atascadero, CA 93422-5808 | |
| (805) 468-2000 | |
| (805) 466-6011 |
| Full Name | Ms Emily K Luk |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 10333 El Camino Real, Atascadero, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023118007 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | G45654 (California) | Primary |
| Entity Name | Department Of State Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124078704 PECOS PAC ID: 9638174238 Enrollment ID: O20081031000305 |
News Archive
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
The House Energy and Commerce Health Subcommittee on Tuesday plans to hold a hearing that "might turn up the heat on congressional leaders to include Medicaid relief for states in a second economic stimulus package," CongressDaily reports.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.
Acne, a scourge of adolescence, may be about to meet its ultra high-tech match. By using a combination of ultrasound, gold-covered particles and lasers, researchers from UC Santa Barbara and the private medical device company Sebacia have developed a targeted therapy that could potentially lessen the frequency and intensity of breakouts, relieving acne sufferers the discomfort and stress of dealing with severe and recurring pimples.
Generex Biotechnology Corporation today announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the first "composition of matter" patent to be issued relating to one of their development products.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Emily K Luk, MD 1600 9th St, Sacramento, CA 95814-6404 Ph: (916) 654-2431 | Ms Emily K Luk, MD 10333 El Camino Real, Atascadero, CA 93422-5808 Ph: (805) 468-2000 |
News Archive
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
The House Energy and Commerce Health Subcommittee on Tuesday plans to hold a hearing that "might turn up the heat on congressional leaders to include Medicaid relief for states in a second economic stimulus package," CongressDaily reports.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.
Acne, a scourge of adolescence, may be about to meet its ultra high-tech match. By using a combination of ultrasound, gold-covered particles and lasers, researchers from UC Santa Barbara and the private medical device company Sebacia have developed a targeted therapy that could potentially lessen the frequency and intensity of breakouts, relieving acne sufferers the discomfort and stress of dealing with severe and recurring pimples.
Generex Biotechnology Corporation today announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the first "composition of matter" patent to be issued relating to one of their development products.
› Verified 4 days ago
Dr. Lisa Thiel Vasak, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5920 West Mall, Atascadero, CA 93422 Phone: 805-466-0676 | |
Albert S Abdel-malek, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10333 El Camino Real, Atascadero, CA 93423 Phone: 805-468-2000 Fax: 805-466-6011 | |
Robin Andrew Alleyne, MD. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7512 Morro Rd, Atascadero, CA 93422 Phone: 805-792-1400 Fax: 805-792-1485 | |
Lymar Galon Bik, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6955 El Camino Real Ste 101, Atascadero, CA 93422 Phone: 805-539-2031 Fax: 805-539-2032 | |
Dr. Jason Anthony Green, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 10333 El Camino Real, Atascadero, CA 93422 Phone: 805-468-2000 | |
Timothy N Tidwell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5920 West Mall, Atascadero, CA 93422 Phone: 805-466-0676 |